Technology

Starpax Biopharma Never-Before-Seen Magnetodrones™ and PolarTrak® Technology Transform Cancer Treatment

Published

3 months ago

June 25, 2024

New 27,000-square-foot manufacturing facility now in operation to produce therapeutic Magnetodrones

MONTREAL, June 25, 2024 /PRNewswire/ — In a significant stride for cancer treatment, Starpax Biopharma Inc. (“Starpax”) today unveiled its Starpax Cancer Treatment Platform™, a groundbreaking innovation that marks a monumental achievement in the company’s journey towards pioneering new frontiers in cancer treatment. With a 100% remission rate and no side effects in all the subjects of the company’s preclinical trials, this technology is conceived to address all solid tumors, representing 90% of cancer and 89% of deaths.

The Starpax technology is addressing a major resistance problem to treatment that chemotherapy and immunotherapy haven’t solved for over a century. Studies have demonstrated that 90% of the volume of a tumor receives little or no drug at all. Drugs or immune cells don’t swim; they need blood vessels to be distributed in a tumor and reach cancer cells, yet blood vessels and lymphatics in a tumor become chaotic, malfunctioning, or collapse. More studies have also demonstrated that as little as 1% of the dose of systemic chemotherapy, such as nanocarriers, antibodies, and precision target drugs, reach a tumor, leaving 99% of the toxic doses free to circulate in the patient’s body, attacking healthy organs and creating unwanted side effects.

The Starpax Magnetodrones™ are the first component of the Starpax Cancer Treatment Platform™. They are living, self-propelled, non-pathogenic bacteria that carry anticancer drugs on their surface and are sensitive to magnetic fields. They are injected directly into a tumor and can swim in tumors without using blood vessels or circulating in the bloodstream.

The Starpax PolarTrak® is the second component of the platform. It is a proprietary medical device in which the patient is installed. It generates unique magnetic fields to keep the Magnetodrones captive inside the tumor, preventing them from escaping into the rest of the patient’s body and forces the Magnetodrones to spread throughout the whole volume of the tumor, including in hypoxic zones where the cancerous stem cells are located. The process is managed by the Polartrak artificial intelligence, based on the data of the patient’s tumor taken from the MRI imagery scanner days before the treatment. Magnetodrones have faced over 800 mutations in the laboratory and therefore are able to detect low levels of oxygen in the tumor’s hypoxia areas where the stem cells are located. Then, they penetrate and accumulate in these areas to introduce the anticancer therapeutic.

“Our breakthrough Starpax platform can save countless lives, offering new hope in the fight against cancer,” said Michael Gareau, Founding President of Starpax. “The unveiling of the Starpax Magnetodrones and PolarTrak lays the foundation for the future of cancer treatment. These technologies are not merely company milestones but keystones in developing solutions that completely transform the way we treat cancer today.”

Direct delivery and spread of anticancer therapeutics into tumors increases efficacy and minimizes damage to healthy tissues. Compared to modern systemic treatments, Starpax’s technology allows the administration of up to 50 times more drug directly in the tumor, including hard-to-reach hypoxic zones. By focusing treatment specifically on the tumor, Starpax’s technology significantly lowers the risk of adverse effects. It allows 800 times fewer toxic molecules to be introduced into the body than standard chemotherapy treatments, drastically reducing toxicity and side effects. The two-part platform of Magnetodrones and PolarTrak creates a safer, more effective alternative to traditional treatments, promising a significant leap in patient care and recovery.

Dr. Gerald Batist, Director of Segal Cancer Center at Jewish General Hospital, stated, “Finally, with the Starpax technology, we have bacteria that actually move towards and can be accumulated in the hypoxic zone. This represents a big step in responding to a challenge that has been there and persists resistance to treatment.”

To manufacture the Starpax Magnetrodrones, the company has also announced its new facility in Montreal is now in operation. When fully operational, the 27,000-square-foot facility has the capacity to produce Magnetodrones to treat 10,000 patients annually. A second Magnetodrones manufacturing plant is being discussed, with a capacity of 110,000 patients annually.

Starting with two patents in 2017, Starpax now holds 57 key patents and pending patents for its Magnetodrones and PolarTrak, as well as the interventional procedure ensuring a competitive edge in the field. Since its founding, Starpax has collaborated with top cancer research institutions, including McGill University, Jewish General Hospital, Polytechnique Montréal, and TransMedTech Institute. In September 2023, the company announced a $24 million Regulation A+ capital raise. It will begin clinical trials in 2025.

About Starpax Biopharma Inc.
Starpax Biopharma Inc. is a biopharma tech company that unites four scientific disciplines: biochemistry, microbiology, electromagnetism engineering, and artificial intelligence to create a never-before-seen technology that is transforming cancer treatment. Its technology aims to overcome the major hurdles of systemic treatments and precisely reach cancer cells throughout tumors, including hypoxic zones, without circulating in the bloodstream, thereby avoiding side effects. To learn more, visit https://starpaxbiopharma.com.

Media Contact
Leigh Brandt
leigh@lightspeedpr.com

View original content:https://www.prnewswire.com/news-releases/starpax-biopharma-never-before-seen-magnetodrones-and-polartrak-technology-transform-cancer-treatment-302181096.html

SOURCE Starpax Biopharma, Inc.

Technology

Mullen & Mullen Law Firm Launches the Mullen & Mullen Music Project

Published

47 mins ago

September 23, 2024

Supporting Local Independent Music Venues and Artists

DALLAS, Sept. 23, 2024 /PRNewswire/ — Dallas based Mullen & Mullen Law Firm proudly announces the launch of the Mullen & Mullen Music Project, a dynamic initiative created in partnership with Spune Productions. The collaboration is designed to celebrate and rejuvenate the North Texas music scene by offering a platform for both emerging and established artists. The initiative kicked off with a Concert Series at local independent music venues.

Supporting Local Talent and Venues
Running from August to April, the Mullen & Mullen Music Project will feature 12 concerts at some of North Texas’s most cherished venues. The series kicked off on August 6th with a performance by Ben Nichols of Lucero at Club Dada. The Quaker City Night Hawks made their triumphant return at Tulips FTW on August 30th after a touring hiatus. The Quaker City Night Hawks concert was filmed on professional grade video cameras installed at the venue by the Music Project and live-edited by the firm’s videographer Sean Pollaro – himself a musician. The new cameras at Tulips FTW will serve as a wonderful content creation tool for local artists.

Enhancing the Music Experience
The Music Project has allowed participating venues to expedite substantial upgrades already underway. Ferris Wheelers Live has enhanced its suites and stage while embarking on an ambitious Ferris Wheel lighting project. Club Dada has upgraded its outdoor patio stage, and Tulips FTW installed the beforementioned state-of-the-art video and streaming system, enabling artists to record music and stream live performances. Each venue will also feature new murals designed and created by local artists.

A Community-Centered Initiative
Shane Mullen, Managing Attorney at Mullen & Mullen Law Firm, shared the firm’s vision: “The trust and loyalty of the North Texas community have been the foundation of our success. This project is our way of giving back by enriching the local cultural landscape and supporting the artists and venues that make our region unique.”

Corey Pond, General Manager of Spune Productions, added: “This initiative addresses the challenges faced by the indie music scene, providing more opportunities for local artists and supporting our cherished venues. It underscores the power of community, collaboration, and the enduring spirit of local music.”

Join Us in Celebrating Local Music
Over the coming months, experience the vibrant revival of North Texas’s music scene with us. Together, let’s strengthen our community while supporting local artists and independent venues. This is our backyard – let’s make it rock!

For more information, visit: https://www.mullenandmullen.com/music/

About Mullen & Mullen Law Firm:
Mullen & Mullen Law Firm has been privileged to represent injured North Texans for over 41 years. The firm is consistently recognized by TopVerdict for obtaining some of the largest personal injury settlements in the entire state of Texas. In the last 4 years, Mullen & Mullen made the “Top 50” list 44 times and the “Top 100” list 70 times. The firm offers the services of two investigators and an award-winning videographer. Website: https://www.mullenandmullen.com

About Spune Productions:
Spune Productions is an independent leader in curating and delivering distinctive music events across Texas. Committed to enhancing communities, Spune specializes in creating impactful experiences that resonate with audiences and reflect clients’ brands. From intimate gatherings to large-scale spectacles, Spune Productions tailors each event to amplify stories through the transformative power of music. Website: https://spune.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/mullen–mullen-law-firm-launches-the-mullen–mullen-music-project-302256220.html

SOURCE Mullen & Mullen Law Firm

Technology

Corteva to Participate in BMO Ag-Apalooza

Published

47 mins ago

September 23, 2024

INDIANAPOLIS, Sept. 23, 2024 /PRNewswire/ — Corteva, Inc. (NYSE: CTVA) announces that Chief Executive Officer, Chuck Magro, will speak at the 2024 BMO Ag-Apalooza event at 12:00 p.m. Eastern Time on Tuesday, September 24, 2024.

Remarks will be webcast live. The webcast can be accessed through the Corteva Investor Relations website. A replay of the presentation will be available 24 hours after the presentation ends and will be accessible until October 24, 2024.

About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the Company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/corteva-to-participate-in-bmo-ag-apalooza-302255653.html

SOURCE Corteva, Inc.

Technology

SEEDING JUSTICE MAKES COMMITMENT TO ENVIRONMENTAL JUSTICE AND ECONOMIC DEVELOPMENT FOR OREGON AND PACIFIC NORTHWEST COMMUNITIES IMPACTED BY MULTIPLE CLIMATE BURDENS ON A GLOBAL STAGE AT THE CLINTON GLOBAL INITIATIVE TODAY

Published

48 mins ago

September 23, 2024

PORTLAND, Ore., Sept. 23, 2024 /PRNewswire/ — Seeding Justice’s Executive Director, Se-ah-dom Edmo, joins global leaders in expanding the nonprofit organization’s commitment to an inclusive green economy focusing on clean energy initiatives created by and for impacted communities.

Click here to watch Seeding Justice’s commitment video and learn more.

What:

Clinton Global Initiative

Who:

Se-ah-dom Edmo, Executive Director, Seeding Justice

When:

September 23, 2024

Where:

New York City, New York

Seeding Justice is a nonprofit organization founded in 1976 and is the region’s largest funder of grassroots organizing and community-led grantmaking.

We focus our work on frontline communities and use community guidance and leadership to help fund the most critical causes, including a new fund to support a community-centered, clean energy future.

Since 2020, our Community Fund program has granted nearly $34 million to communities across the state through Funds like the Reproductive Health Equity Fund and the Child Care Capacity Building Fund. Seeding Justice is also the founding funder of Oregon Worker Relief, the largest program of its kind in the state, and has supported the dispersal of more than $180 million through the Fund, which helps immigrant Oregonians make ends meet.

View original content to download multimedia:https://www.prnewswire.com/news-releases/seeding-justice-makes-commitment-to-environmental-justice-and-economic-development-for-oregon-and-pacific-northwest-communities-impacted-by-multiple-climate-burdens-on-a-global-stage-at-the-clinton-global-initiative-today-302256239.html

SOURCE Seeding Justice